Schroder UK Public Private Trust plc
|Rutherford Health PLC||18.47 %|
|Crossco (1337) Plc||16.90 %|
|Oxford Nanopore Tech Ord||15.70 %|
|Immunocore Limitied Ser A||5.77 %|
|Mission Therapeutics||3.76 %|
|Autolus Therapeutics PLC ADR||3.54 %|
|Evofem Biosciences Inc||2.75 %|
|Reaction Engines Ord Link||2.64 %|
|Kymab B Pref. Share||2.55 %|
|United Kingdom||84.97 %|
|United States||10.26 %|
Joined Schroders in 2013. Investment career commenced in 1999. Ben assumed the role of Global Sector Specialist for Energy within Schroders’ London-based Global & International Equity team in September 2013. Prior to this, he was an equity analyst supporting the team’s research effort. Ben initially joined Schroders in 1999 as a graduate. From 2000 Ben was an analyst with Schroders’ Pan European research team where he had responsibility for construction, basic materials and oil & gas sectors. He later became a global basic materials sector specialist and spent time working as an EAFE portfolio manager. Ben left Schroders in 2005 to work for the UK Government as a senior analyst conducting geopolitical risk analysis before returning in 2013. BA (Hons) from Oxford University in History and Modern Languages (French).
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.